Yamazaki O - Search Results

1

Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.

Uenishi T, Yamazaki O, Tanaka H, Takemura S, Yamamoto T, Tanaka S, Nishiguchi S, Kubo S. Uenishi T, et al. Among authors: yamazaki o. Ann Surg Oncol. 2008 Feb;15(2):583-9. doi: 10.1245/s10434-007-9650-y. Epub 2007 Oct 23. Ann Surg Oncol. 2008. PMID: 17955299

2

Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.

Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Shuto T, Tanaka H, Kinoshita H. Uenishi T, et al. Among authors: yamazaki o. Hepatogastroenterology. 2003 Jul-Aug;50(52):1069-72. Hepatogastroenterology. 2003. PMID: 12845984

3

Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma.

Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T. Yamamoto S, et al. Among authors: yamazaki o. Cancer Sci. 2004 Jul;95(7):592-5. doi: 10.1111/j.1349-7006.2004.tb02492.x. Cancer Sci. 2004. PMID: 15245596 Free PMC article.

4

Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.

Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S, Hai S, Kubo S. Uenishi T, et al. Among authors: yamazaki o. J Hepatobiliary Pancreat Surg. 2005;12(6):479-83. doi: 10.1007/s00534-005-1026-8. J Hepatobiliary Pancreat Surg. 2005. PMID: 16365823

5

Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma.

Hai S, Kubo S, Yamamoto S, Uenishi T, Tanaka H, Shuto T, Takemura S, Yamazaki O, Hirohashi K. Hai S, et al. Among authors: yamazaki o. Dig Surg. 2005;22(6):432-9. doi: 10.1159/000091446. Epub 2006 Feb 10. Dig Surg. 2005. PMID: 16479112

6

Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma.

Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S, Hai S, Ono K, Kubo S. Uenishi T, et al. Among authors: yamazaki o. J Hepatobiliary Pancreat Surg. 2006;13(3):239-44. doi: 10.1007/s00534-005-1069-x. J Hepatobiliary Pancreat Surg. 2006. PMID: 16708302

7

Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.

Uenishi T, Kubo S, Yamazaki O, Yamada T, Sasaki Y, Nagano H, Monden M. Uenishi T, et al. Among authors: yamazaki o. J Hepatobiliary Pancreat Surg. 2008;15(4):417-22. doi: 10.1007/s00534-007-1315-5. Epub 2008 Aug 1. J Hepatobiliary Pancreat Surg. 2008. PMID: 18670844

8

Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma.

Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Kinoshita H. Uenishi T, et al. Among authors: yamazaki o. Br J Surg. 2001 Jul;88(7):969-74. doi: 10.1046/j.0007-1323.2001.01784.x. Br J Surg. 2001. PMID: 11442529

9

Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B.

Kubo S, Hirohashi K, Yamazaki O, Matsuyama M, Tanaka H, Horii K, Shuto T, Yamamoto T, Kawai S, Wakasa K, Nishiguchi S, Kinoshita H. Kubo S, et al. Among authors: yamazaki o. World J Surg. 2002 May;26(5):555-60. doi: 10.1007/s00268-001-0267-1. Epub 2002 Feb 19. World J Surg. 2002. PMID: 12098045

10

Clinicopathologic characteristics of small intrahepatic cholangiocarcinomas of mass-forming type.

Kubo S, Uenishi T, Yamamoto S, Hai S, Yamamoto T, Ogawa M, Takemura S, Shuto T, Tanaka H, Yamazaki O, Hirohashi K, Kinoshita H. Kubo S, et al. Among authors: yamazaki o. Hepatol Res. 2004 Aug;29(4):223-227. doi: 10.1016/j.hepres.2004.03.010. Hepatol Res. 2004. PMID: 15288015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters